[{"NetIncomeLoss_1_Q2_USD":-53239000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":13216000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":127354540.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":127482127.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestIncomeOther_2_Q2_USD":25000.0,"InterestIncomeOther_1_Q2_USD":10000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":4200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-8243000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27226000.0,"OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":331782000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":22035000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":16121000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":22320993.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1394000.0,"CommonStockSharesIssued_0_Q2_shares":127584659.0,"Assets_0_Q2_USD":391004000.0,"ShareBasedCompensation_2_Q2_USD":11321000.0,"AccruedSalariesCurrentAndNoncurrent_0_Q2_USD":5271000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":23888000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Liabilities_0_Q2_USD":97117000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":37294000.0,"PrepaidExpenseOtherNoncurrent_0_Q2_USD":1926000.0,"OtherLongTermDebt_0_Q2_USD":236000.0,"PaymentsOfFinancingCosts_2_Q2_USD":115000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3164000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2739000.0,"CommonStockValue_0_Q2_USD":13000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":664000.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":15625000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":33706000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":1482000.0,"OtherAssetsCurrent_0_Q2_USD":125000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":22035000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-104220000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-53239000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1485000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":327060000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":32907000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":1325000.0,"ContractualObligation_0_Q2_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-104220000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-53239000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5261000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-82026000.0,"LiabilitiesCurrent_0_Q2_USD":29257000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-56563000.0,"AccountsPayableCurrent_0_Q2_USD":4986000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":331260000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":632000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4722000.0,"AdditionalPaidInCapital_0_Q2_USD":789004000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":331260000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q2_USD":541000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":435000.0,"PrepaidInsurance_0_Q2_USD":1501000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":28032000.0,"NetIncomeLoss_2_Q2_USD":-104220000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":743000.0,"CommonStockSharesOutstanding_0_Q2_shares":127584659.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-495130000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2270000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"OperatingIncomeLoss_2_Q2_USD":-101081000.0,"OperatingIncomeLoss_1_Q2_USD":-50510000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":391004000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11321000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5184000.0,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":635000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2236000.0,"OperatingExpenses_2_Q2_USD":101081000.0,"OperatingExpenses_1_Q2_USD":50510000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.82,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.42,"ProfitLoss_2_Q2_USD":-104220000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2711000.0,"StockholdersEquity_0_Q2_USD":293887000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":8243000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":73855000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1515000.0,"Ticker":"CERE","CIK":"1805387","name":"CEREVEL THERAPEUTICS HOLDINGS, INC.","OfficialName":"Cerevel Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4823550476.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]